from 4 to 16 h were -10-fold those in UUL(U) or UUL(R) kidneys. (c) The significant decline in glomerular concentration between 4 and 16 h in control and nonobstucted kidneys was not observed in UUL(R), UUL(U), or BUL (released or unreleased) kidneys; in all obstructed kidneys, a plateau in glomerular concentrations of AHIgG125I was observed between 4 and 16 h. (d) After 16 h at a time when the blood level of AHIgG125I had decreased to 3% of initial values, there was progressive fall in glomerular AHIgG'25I. Similar results were obtained in the uremia-control group in rats, which indicated that uremia per se had no measurable effect on mesangial kinetics. These studies demonstrate that ureteral occlusion induces alterations in mesangial uptake (afferent limb) and egress (efferent limb) of macromolecules. Particularly evident is the "blockade" of the efferent limb which is demonstrable at high blood levels of AHIgG125I. These alterations in the transit of macromolecules through the mesangium may be mediated in part by the hemodynamic changes that accompany ureteral obstruction. INTRODUCTION The glomerular mesangium occupies an intercapillary position and consists of mesangial cells and an amorphous fibrillar material, the mesangial matrix (1) . Anatomically, it is separated from the capillary lumen by the endothelium and limited by the mesangial reflexion of the glomerular basement membrane (2) .
The contiguity with the lacis cells of the juxtaglomerular (JG)l zone and the presence of actomyosin suggest that it may play a role in the regulation of the glomerular 1Abbreviations and nomenclature used in this paper:
AHIgG125I, radiolabeled aggregated human IgG; BUL, bilateral ureteral ligation; BUN, blood urea nitrogen; GFR, glomerular filtration rate; JG, juxtaglomerular; PGC, glomerular capillary pressure; RBF, renal blood flow; SNGFR, single nephron GFR; UUL(R), unilateral ureteral ligation with left ureter released; UUL(U), unilateral ureteral ligation with left ureter unreleased. blood flow (3, 4) . In addition, morphological studies with a variety of probes have demonstrated movement of macromolecules into the mesangium by way of the endothelial fenestra and the mesangial endothelial interface (5) (6) (7) (8) . This mesangial uptake (afferent limb) is dependent in part upon type, size, and blood level of the macromolecule (8) . The mechanisms controlling the clearing of macromolecules (efferent limb) are incompletely understood, but depend upon phagocytosis, passage by way of the glomerular stalk to the JG region, and possibly regurgitation into the glomerular circulation (8) .
Whether the hemodynamic determinants of glomerular filtration modulate the mesangial traffic of macromolecules has not been defined. Unilateral and bilateral ureteral ligation are known to induce alterations in these determinants, particularly renal blood flow (RBF), glomerular capillary pressure (PGC), and tubular pressure (9) (10) (11) (12) (13) (14) . Ureteral obstruction is also accompanied by changes in the renal interstitium and renal lymph flow (15, 16) . We have studied mesangial uptake and disappearance of radiolabeled aggregated human immunoglobulin (Ig)G (AHIgG125I), a polydispersed population of macromolecules with characteristics similar to those of antigen-antibody complexes, in normal rats and in rats with unilateral and bilateral ureteral ligation of 24-h duration. In the experiments reported here, we have shown a marked alteration in mesangial uptake and egress of macromolecules after ureteral obstruction of 24-h duration. Specifically, ureteral occlusion induces a "blockade" in the transport of AHIgG125I out of the mesangium (efferent limb) which is demonstrable at high blood levels ofAHIgG125I.
Preparation of AHIgG125I
Human immune serum globulin (E. R. Squibb and Sons, New Brunswick, N. J.) was labeled with 125I (New England Nuclear, Boston, Mass.) by the chloramine-T method of McConahey and Dixon (17) . The efficiency of labeling was =55%, and the quantity of free 1251 in the final product was <3%. From this labeled protein, AHIgG'251 was prepared by heat aggregation according to the methods of Christian (18) and Ishi7aka and Ishizaka (19) as modified by Mauer et al. (6, 7) .
The final concentration ofAHIgG'251 was adjusted to contain 60 mg of protein/ml; merthiolate was added to a final concentration of 1:10,000. Free 125I in this preparation was <1%, and the specific activity of the solution was 0.1 mCi/mg of protein. The AHIgG'251 was stored at room temperature and used within a week of its preparation. Immediately before the injection of AHIgG125I to animals, the solution was centrifuged at 5,000 g to remove insoluble aggregates. Tissue and blood analysis. The control and experimental animals to be killed 24 h after the administration ofAHIgG125I were placed in metabolic cages, and all urines were collected. Protein-bound 1251 in urine was investigated by the addition of 2 ml of 10% TCA to 2 ml of urine. From each of the experimental and control animals sacrificed at the various time intervals, the kidneys were removed; the left and right kidneys were pooled separately for determination of AHIgG'25I in preparations of isolated glomeruli (see below). In addition, small wedge sections were taken from left and right kidneys of all control and experimental animals for histologic studies. Liver and spleen from experimental and control animals were also removed for determination of AHIgG125I. The blood obtained at the time of sacrifice was used for determination of blood urea nitrogen (BUN), protein bound 1251, and for sucrose density gradient centrifugation.
Renal histology
Wedge-shaped renal tissue obtained at the time of sacrifice was prepared for light and immunofluorescence microscopic studies by techniques previously described (20) . The intensity of immunofluorescence was arbitrarily graded from negative to 3+. Within each specimen the intensity and pattern of fluorescence in superficial and juxtamedullary glomeruli were compared.
Quantitation of AHIgG125I in preparations of isolated glomeruli Glomerular isolates were prepared separately from pools of five left and five right kidneys from experimental and control animals sacrificed at the different time intervals after administration of AHIgG125I. The kidneys were decapsulated and medulla was separated from cortex. The mash of decapsulated cortex was pushed through a 150-mesh screen (Michigan Dynamics, Div. of Ambac Industries, Inc., Garden City, Mich.). The resulting suspension was poured through a 100-mesh screen to remove large tissue fragments; the glomeruli were then collected on 200-and 325-mesh screens successively, and washed vigorously with 0.15 M sodium chloride into a 50-ml centrifuge tube. Glomerular preparations were examined by phase microscopy to insure at least an 85% purity.
The glomeruli were then washed, lyophilized, and weighed and counted in a Biogamma II counter (Beckman Instruments, Inc., Fullerton, Calif.) for 1251. The data were expressed as micrograms of AHIgG125I per milligram of dried glomeruli. Protein-bound 125I in combined supernates from glomerular washes was <0.16% of the measured radioactivity in a given pool of glomeruli, which indicates that mesangial-trapped AHIgG'251 was not released during the washing procedure.
The contamination of isolated glomeruli by blood was demonstrated to be minimal (0.002 ml serum/mg glomeruli) in separate experiments after administration ofnonaggregated 7S IgG125I; correction of glomerular concentration ofAHIgG'25I for entrapped serum resulted in minimal differences from uncorrected values (<7.0%). 2 Quantitation of AHIgG125I in preparations of liver and spleen Liver and spleen were removed from each animal at the time of sacrifice. The tissues were thoroughly washed in isotonic saline and dried in a ventilated oven at 85°C for 24 h. The dried organs were weighed, placed in 1.0 N sodium hydroxide that contained 0.2 N sodium deoxycholate, and then dissolved by heating at 95°C for 1 h. The dissolved tissue was then counted for 1251; the data were expressed as micrograms of AHIgG'251 per milligram ofdried tissue. No attempt was made to correct for residual blood contamination in liver and spleen because the AHIgG125I content in these organs was used to exclude major differences in reticuloendothelial function among experimental groups. We have not demonstrated differences in these data after perfusion of the liver with saline until free of blood.2
Quantitation of AHIgG125I in blood
Whole blood (0.1 ml) was added to 2.0 ml of 0.1% sodium carbonate to produce hemolysis. After total counts for 125I were obtained, 2.0 ml of 10% TCA was added to produce protein precipitation. The samples were centrifuged at 5,000 g, and the supemate was separated and counted to determine free 1251; protein bound counts were calculated by subtraction. Serum (0.2 ml) was layered on a 12-ml linear sucrose gradient (10-50% sucrose). Gradients were centrifuged at 36,000 rpm for 16 h at 4°C with a SW 40 rotor in a Beckman ultracentrifuge (model L5-65, Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.). Fractions (0.5 ml) were collected through a hole in the bottom of the tube and counted for 125I. The gradient curves were integrated, and blood levels of AHIgG125I >7S were calculated (21) .
Determination of RBF and arterial pressure RBF was determined in six animals in each of the following groups: (a) control animals: RBF was determined in the left kidney 24 h after the sham operation; (b) BUL animals: 1 h after release of the left ureter, RBF was measured in both kidneys; (c) UUL(R) animals: RBF was separately determined in both kidneys 1 h after the release of the left ureter; and (d) UUL(U) animals: RBF was measured in both kidneys.
Animals were anesthesized with sodium pentobarbitol (50 mg/kg of body wt) intraperitoneally, and the femoral artery was cannulated with PE 50 polyethylene tubing. Micropuncture studies 24 h after either unilateral or bilateral ureteral obstruction, animals were prepared for micropuncture studies as previously described (22) . Isotonic saline that contained 20 mg/ml of inulin was infused via a jugular vein catheter (PE 50) at a rate of 2 (24, 25) . Tubular fluid volume was measured with a previously calibrated micropipette. Inulin concentrations in blood, tubular fluid, and urine were determined in duplicate by the microfluorometric method (22) . In UUL(U) rats, no micropuncutre studies were performed. Inulin clearance was determined in the right unobstructed kidney 24 h after the ligation of the left kidney.
Statistical analysis
Where applicable, data are expressed as mean±standard error of the mean. Physiologic data were compared in control and experimental animals with the Student's t test. Linear regression in the experimental and control animals was performed, and slopes were compared by standard techniques.
RESULTS
Blood levels of >7S AHIgG125I were determined in control and experimental animals (Fig. 2) (Fig. 4) , which demonstrated that uremia per se did not influence mesangial kinetics of AHIgG125I.
Immunofluorescence and light microscopy
At 2 h, human AHIgG, detected with fluorescein isothiocyanate-labeled goat anti-human IgG, was present primarily within the mesangium but also in a subendothelial distribution. By 4 h, human IgG was found almost entirely within the mesangium. Minimal fluorescence was seen in peritubular capillaries, but none was observed in tubules or Bowman's space. This pattern of fluorescence was similar in control and experimental kidneys. However, the intensity of fluorescent staining was different in the control and experimental kidneys at the various time intervals but showed an excellent correlation with the quantitative determination of AHIgG125I in isolated glomeruli. In control and nonobstructed kidneys of UUL(U) and UUL(R), mesangial immunofluorescence was intense (2-3+) at 2, 4, and 8 h after administration of AHIgG125I, with a decrease to trace amounts by 24 h. In obstructed kidneys from UUL(R) and UUL(U), the intensity of immunofluorescence (1 +) was the same at all time periods and became negative by 24 h. Evaluation of BUL kidneys, whether released or unreleased, revealed striking fluorescence (3+) at 4, 8, and 16 h, with a lesser intensity (1+) at 2 and 24 h. In addition, tissue obtained by wedge biopsy from control and experimental animals revealed that at all time intervals studied there were no differences in the intensity of mesangial staining between cortical and deep glomeruli. Light microscopy revealed only tubular dilatation, mild epithelial cell flattening, and interstitial edema in obstructed kidneys.
AHIgG125I in liver and spleen
Despite striking differences in mesangial AHIgG125I between control and experimental animals, there were no major differences in AHIgG125I concentrations in the liver and spleens among control and UUL(U), UUL(R), and BUL rats (Fig. 5) . In both organs there was a progressive decrease in AHIgG125I concentration, and, by 24 h, <1% of the initial concentration was present. Linear regression analysis ofthe slopes derived from data for liver and spleen showed no significant differences between experimental and control animals.
Physiological studies RBF was significantly decreased in all models of ureteral obstruction (Table I ). The RBF of unreleased kidneys in BUL and UUL(U) animals was reduced to Hours after AHIgG 1251 administration FIGURE 5 The concentration of AHIgG125I in livers and spleens of control and experimental animals sacrificed at various time intervals. Each plot represents the mean value of data obtained from two separate experiments. (Table II) .
Comparison of glomerular dynamic factors between released kidneys of BUL and UUL(R) animals is presented in Table II . After ureteral release, the hydrostatic pressures in the proximal tubules were lower than normal in both models. Compared with control rats, single nephron glomerular filtration rate (SNGFR) and the calculated PGC were reduced in the released kidneys of BUL and UUL animals. It is apparent that in both of these models the reduced PGC can be explained by vasoconstriction of the afferent arteriole. Calculations of resistance changes across the afferent arteriole from the changes in blood flow and pressures indicated that the increase in resistance was similar in both UUL(R) and BUL kidneys. However, PGC in released kidneys of BUL animals was higher than in the released kidneys of UUL(R) animals. This increase can be explained by the higher mean arterial pressure observed in BUL animals (Table II) . However, SNGFR was not significantly different between BUL and UUL(R) kidneys. This suggests that the glomerular capillary ultrafiltration coefficient, may be lower in BUL than UUL(R) kidneys. Whole kidney glomerular filtration rate (GFR) in both models was proportionately more decreased than SNGFR, which suggests nephron GFR heterogeneity, although back leak of glomerular filtrate (13) or sample errors may be contributory factors. Although these variables conceivably could affect the accuracy of the data, the methods and results are similar to that reported by other investigators (9, 10, 12) .
DISCUSSION
After the administration of AHIgG125I to the normal rat, kinetic studies have shown a rapid increase in UV, urine volume; C1, inulin clearance; A, plasma oncotic pressure; P, tubular pressure; SFP, stop-flow pressure; MAP, mean arterial pressure.
mesangial uptake within a period of 2-4 h after administration, followed by a decline over the subsequent 24 h. The initial uptake, which occurs during a period of relatively high blood levels, and the subsequent falloff can be described in terms ofafferent and efferent limbs, respectively (8) . These phases are not separate events because efferent mechanisms likely come into play during the initial uptake period, and, therefore, no time line can clearly separate one phase from the other. Prior studies have demonstrated that uptake of AHIgG, immune complexes, and other macromolecules may be increased (a) after the elevation of the blood level, either by raising the dose or by impairing systemic mononuclear phagocytic uptake (5, 7, 26, 27) , and (b) after the administration of anti-GBM antibody or aminonucleoside ofpuromycin (6, 7) . In both situations the efferent limb appears to be intact. The localization ofAHIgG in the mesangium is dependent upon delivery rate to the capillary lumen (the concentration in the blood times glomerular blood flow) as well as on transfer from the lumen to the mesangium. In all models of ureteral obstruction reported here, we observed a marked decrease in 2-h mesangial AHIgG125I. Because at the time, blood levels of AHIgG125I in experimental and control animals were high, this reduced uptake suggests a decrease in either delivery of AHIgG125I or in transfer from the capillary to the mesangium (lumenmesangial transfer) or in both. Indeed, a decrease in delivery rate ofaggregates produced by a 50% reduction in RBF secondary to aortic constriction causes a proportionate decrease ofthe same magnitude in the mesangial AHIgG125I.2 The reduction in RBF to 50% of normal in UUL(U) and in unreleased BUL kidneys could be the reason for diminished 2-h uptake of AHIgG125I in these models. However, this does not explain completely the similar decrease in 2-h mesangial AHIgG125I in released BUL and UUL(R) kidneys, which have a higher RBF, 86% and 71% of normal, respectively. Hence, a similar decrease in 2-h mesangial AHIgG125I in all experimental models despite different RBF would suggest that impaired lumen-mesangial transfer ofaggregates may also be a contributing factor. If this assumption is correct, lumen-mesangial transfer of aggregates in BUL kidneys is less impaired than in UUL kidneys.
Mesangial AHIgG125I in BUL kidneys increased in the period from 2-4 h, whereas in UUL(R) and UUL(U), mesangial AHIgG125I decreased. The reason for this difference is unknown, although several explanations may be entertained. First, this may be a consequence of differences in capillary pressure and/or permeability. The capillary pressure was lower than normal in all models of ureteral obstruction of 24-h duration but was higher in BUL and UUL(R) kidneys. In addition, although not specifically determined in these experiments, the glomerular capillary ultrafiltration coefficient appeared lower in BUL than UUL(R). Second, the higher concentration of AHIgG125I at 4 h in BUL compared with UUL may result from the differences in uptake described above superimposed on efferent mesangial blockade (see below). Third, these findings may be related to differences in the time-course of uptake, i.e., rapid in UUL so that maximal uptake had already occurred by 2 h, and retarded in BUL with maximum uptake at 4-8 h. However, this latter hypothesis does not explain the plateau at 4-16 h in UUL animals.
Ureteral release did not substantially alter mesangial kinetics in either BUL or UUL kidneys, which suggests that the factors inducing abnormal kinetics persisted after release of ureteral obstruction. Other studies have shown that alterations in glomerular function persist for at least 24 h after release of ureteral obstruction (28) .
The mechanisms that control the disappearance of macromolecules from the mesangium or efferent limb are unclear. In previous studies, intracellular degradation by mesangial cells was postulated as a primary mechanism (1, 29) . However, the predominant localization of certain macromolecules such as antigen-antibody complexes (30) and aggregated proteins (5) within the mesangial channels and not within mesangial cells suggests that this may not be the main mechanism. Passage by way of the glomerular stalk to the JG zone has been clearly demonstrated with morphologic techniques, although the pathway thereafter is obscure (31, 32) . It is possible that drainage into the lymphatics, interstitium, or tubules may occur, although none of these routes has been proven. Regurgitation into the glomerular circulation is theoretically possible but has not been shown by morphologic techiques. For any given blood level of macromolecules, mesangial concentration is determined by a dynamic process that depends upon the balance between the afferent and efferent limb. As previously noted, after intravenous injection into normal animals, blood and glomerular levels of AHIgG125I decreased linearly over 24 h. The disappearance of macromolecules in obstructed kidneys from UUL(R), UUL(U), and BUL animals was markedly different from normal: a common feature in all three groups was the lack of a significant decrease in mesangial AHIgG125I between 4 and 16 h despite the progressive decrease in blood levels of AHIgG125I. These findings suggest a blockade of the mesangial efferent limb. The level of mesangial AHIgG125I at which the 4 to 16-h plateau occurred was different among the experimental models, and, in each model, a function of the mesangial concentration of AHIgG125I present at 4 h. In that respect, in both the released and unreleased kidneys of BUL animals, this plateau was 10-fold greater than that observed in UUL(U) or UUL(R). The observed alterations in mesangial kinetics were a result of intrarenal factors because there were no differences in the blood levels of AHIgG25I among any of the groups. During the 16-to 24-h period of time, a progressive decrease in mesangial AHIgG125I occurred in obstructed as well as control kidneys.
The reason for the blockade in the transport of AHIgG125I out of the mesangium of kidneys with ureteral obstruction is unclear. During the 4-to 16-h time period, the concentration of AHIgG125I in the blood was relatively high, which suggests that the lack of decrease in mesangial concentration was dependent upon high levels of circulating AHIgG125I. However, during the 16-to 24-h time period, a significant decrease in mesangial concentration occurred in all models associated with blood levels that were <3% of initial values. These observations suggest at least two mechanisms for disposal of macromolecules from the mesangium: one which is abrogated by ureteral obstruction and is detected at high levels of circulating AHIgG125I and the other which is not affected by ureteral occlusion and is evident at low blood concentrations. One possibility to explain these observations is that ureteral obstruction impairs traffic by way of the glomerular stalk to the JG region. At high blood levels, glomerular concentrations change little because of a dynamic equilibrium between the circulating and mesangial pools of AHIgG125I. As the blood concentration decreases to low values at the 16-to 24-h time period, this equilibrium becomes imbalanced, and, despite continued ureteral obstruction, egress from the mesangium occurs. This loss may be a consequence of regurgitation of AHIgG125I into the circulation by way of the glomerular capillary and/or degradation after pinocytosis and phagocytosis.
Whereas previous physiologic and morphologic studies in animals with ureteral obstruction suggest the nephron function may be heterogenous (10), we were unable to demonstrate differences between cortical and juxtamedullary glomerular uptake of AHIgG125I in any ofthe models using semiquantitative immunofluorescence microscopy. However, with this technique, subtle differences in mesangial AHIgG'25I may not be appreciated. From the studies performed in uremia-control rats, it is apparent that the differences in the mesangial kinetics between BUL, UUL, and control animals cannot be explained by uremia per se. In addition, in other studies we have shown that rats made acutely uremic with mercury chloride have normal mesangial uptake and release of AHIgG125I (33) .
The analysis of physiologic parameters measured in these experiments suggests that no single factor can explain the observed differences in mesangial kinetics. These studies do, however, demonstrate that the alterations induced by ureteral obstruction markedly influence the afferent and efferent limb of the mesangium. The possibility that some of these changes in mesangial kinetics may be related to retention or increased production of vasoactive materials cannot be excluded. Experimental data have shown that hydronephrotic kidneys produce increased amounts of the vasodilator prostaglandin E2 and the vasoconstrictor thromboxane A2 (34) (35) (36) . It is interesting to speculate that these mediators or similar vasoactive substances, including angiotensin II (37) , could modulate the mesangial afferent and/or efferent limbs by acting upon the contractile elements of the mesangium.
Clinically, the experiments reported here may have a bearing upon the recent report of Mathew et al. (38) , who demonstrated that transplanted kidneys with persistent ureteral reflux develop mesangial proliferative changes, findings not present in the original kidneys.
